Остеопороз и остеопатии | |
THE RELEVANCE, BENEFITS AND CLINICAL PERSPECTIVES OF THE COMBINED TREATMENT OF OSTEOPOROSIS BASED ON BONE-ANABOLIC THERAPY | |
L A Marchenkova1  E Yu Martynova1  | |
[1] ФГБУ «Российский научный центр медицинской реабилитации и курортологии» Минздрава России; | |
关键词: остеопороз; терипаратид; комбинированная терапия; последовательная терапия; | |
DOI : 10.14341/osteo2015220-24 | |
来源: DOAJ |
【 摘 要 】
Combination therapy of osteoporosis based on bone-anabolic and antiresorbtive agents has a great clinical perspective. An analysis of available publications shows that combination therapy is appropriate from the standpoint of increasing the effectiveness of treatment. Combination therapy can be executed as a simultaneous use of teriparatide with denosumab, raloxifene or hormonal therapy, and the subsequent administration of bisphosphonates, denosumab or raloxifene after treatment with teriparatide. The review presents the evidence-based data on the effect of combined and sequential regimens for osteoporosis fracture risk.
【 授权许可】
Unknown